Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin Prophylaxis in Azacitidine-Treated MDS and AML (AZABAC)
NCT03594149Phase 3Completed
- Sponsor
- Centre Henri Becquerel
- Start
- Jul 2018
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levofloxacin in bacterial infection, sponsored by Centre Henri Becquerel. Started Jul 2018; status: completed.
02
Drugs
levofloxacin
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT03594149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03594149.